[开放获取]    窄谱中波紫外线联合其他方法治疗白癜风的研究进展

doi:10.35541/cjd.20210010

Abstract

Abstract: 【Abstract】 Narrow-band ultraviolet B （NB-UVB） phototherapy has been regarded as the first-line treatment of generalized vitiligo. However, NB-UVB monotherapy exhibits limited efficacy with a long course of treatment. NB-UVB phototherapy combined with other therapies can shorten the course of treatment and improve the therapeutic effect, and has become a commonly used therapeutic regimen in clinical practice. This review summarizes research progress in NB-UVB combined with other therapies for the treatment of vitiligo, such as glucocorticoids, afamelanotide, calcineurin inhibitors, Janus kinase inhibitors, platelet-rich plasma, fractional carbon dioxide laser and surgical treatment, in order to provide more treatment options for clinical treatment of vitiligo.

Key words: Vitiligo, Ultraviolet therapy, Narrow-band ultraviolet B, Combined therapy

Zeng Rui, Xu Xiulian. Narrow-band ultraviolet B phototherapy combined with other therapies for the treatment of vitiligo[J]. Chinese Journal of Dermatology, 2024, 57(1): 75-78.doi:10.35541/cjd.20210010

References ［29］

［1］	Bae JM, Ju HJ, Lee RW, et al. Evaluation for skin cancer and precancer in patients with vitiligo treated with long⁃term narrowband UV⁃B phototherapy［J］. JAMA Dermatol, 2020,156（5）:529⁃537. doi: 10.1001/jamadermatol.2020.0218.
［2］	中国中西医结合学会皮肤性病专业委员会色素病学组. 白癜风诊疗共识（2018版）［J］. 中华皮肤科杂志, 2018,51（4）:247⁃250. doi: 10.3760/cma.j.issn.0412⁃4030.2018.04.001.
［3］	Mohammad TF, Al⁃Jamal M, Hamzavi IH, et al. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo［J］. J Am Acad Dermatol, 2017,76（5）:879⁃888. doi: 10.1016/j.jaad.2016.12.041.
［4］	中国医师协会皮肤科医师分会规范化诊疗工作委员会, 中国医学装备协会皮肤病与皮肤美容专业委员会皮肤外科装备学组和皮肤光治疗学组. 窄谱中波紫外线家庭光疗临床应用专家共识［J］. 中华皮肤科杂志, 2019,52（3）:156⁃161. doi: 10.3760/cma.j.issn.0412⁃4030.2019.03.002.
［5］	许爱娥, 雷杰豪, 樊奇敏. 窄谱中波紫外线治疗白癜风治疗参数选择［J］. 中华皮肤科杂志, 2020,53（2）:89⁃92. doi: 10. 35541/cjd.20190523.
［6］	Lee J, Chu H, Lee H, et al. A retrospective study of methylprednisolone mini⁃pulse therapy combined with narrow⁃band UVB in non⁃segmental vitiligo［J］. Dermatology, 2016,232（2）:224⁃229. doi: 10.1159/000439563.
［7］	茅於彤, 朱晓芳, 王琴, 等.卤米松乳膏联合窄谱中波紫外线治疗白癜风疗效观察［J］. 中国美容医学, 2012,21（4）:615⁃616. doi: 10.15909/j.cnki.cn61⁃1347/r.2012.04.075.
［8］	Grimes PE, Hamzavi I, Lebwohl M, et al. The efficacy of afamelanotide and narrowband UV⁃B phototherapy for repigmentation of vitiligo［J］. JAMA Dermatol, 2013,149（1）:68⁃73. doi: 10.1001/2013.jamadermatol.386.
［9］	Lim HW, Grimes PE, Agbai O, et al. Afamelanotide and narrowband UV⁃B phototherapy for the treatment of vitiligo: a randomized multicenter trial［J］. JAMA Dermatol, 2015,151（1）:42⁃50. doi: 10.1001/jamadermatol.2014.1875.
［10］	Toh J, Chuah SY, Jhingan A, et al. Afamelanotide implants and narrow⁃band ultraviolet B phototherapy for the treatment of nonsegmental vitiligo in Asians［J］. J Am Acad Dermatol, 2020,82（6）:1517⁃1519. doi: 10.1016/j.jaad.2020.01.035.
［11］	Nordal EJ, Guleng GE, Rönnevig JR. Treatment of vitiligo with narrowband⁃UVB （TL01） combined with tacrolimus ointment （0.1%） vs. placebo ointment, a randomized right/left double⁃blind comparative study［J］. J Eur Acad Dermatol Venereol, 2011,25（12）:1440⁃1443. doi: 10.1111/j.1468⁃3083.2011.04002.x.
［12］	Arora CJ, Rafiq M, Shumack S, et al. The efficacy and safety of tacrolimus as mono⁃ and adjunctive therapy for vitiligo: a systematic review of randomised clinical trials［J］. Australas J Dermatol, 2020,61（1）:e1⁃1e9. doi: 10.1111/ajd.13096.
［13］	Lee JH, Kwon HS, Jung HM, et al. Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: a systematic review and meta⁃analysis［J］. JAMA Dermatol, 2019,155（8）:929⁃938. doi: 10.1001/jamadermatol.2019.0696.
［14］	Dang YP, Li Q, Shi F, et al. Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta⁃analysis［J］. Dermatol Ther, 2016,29（2）:126⁃133. doi: 10.1111/dth.12295.
［15］	Relke N, Gooderham M. The use of Janus kinase inhibitors in vitiligo: a review of the literature［J］. J Cutan Med Surg, 2019,23（3）:298⁃306. doi: 10.1177/1203475419833609.
［16］	Karagaiah P, Valle Y, Sigova J, et al. Emerging drugs for the treatment of vitiligo［J］. Expert Opin Emerg Drugs, 2020,25（1）:7⁃24. doi: 10.1080/14728214.2020.1712358.
［17］	Rothstein B, Joshipura D, Saraiya A, et al. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib［J］. J Am Acad Dermatol, 2017,76（6）:1054⁃1060.e1. doi: 10.1016/j.jaad. 2017.02.049.
［18］	Kim SR, Heaton H, Liu LY, et al. Rapid repigmentation of vitiligo using tofacitinib plus low⁃dose, narrowband UV⁃B phototherapy［J］. JAMA Dermatol, 2018,154（3）:370⁃371. doi: 10.1001/jamadermatol.2017.5778.
［19］	Mobasher P, Guerra R, Li SJ, et al. Open⁃label pilot study of tofacitinib 2% for the treatment of refractory vitiligo［J］. Br J Dermatol, 2020,182（4）:1047⁃1049. doi: 10.1111/bjd.18606.
［20］	Phan K, Phan S, Shumack S, et al. Repigmentation in vitiligo using janus kinase （JAK） inhibitors with phototherapy: systematic review and Meta⁃analysis［J］. J Dermatolog Treat, 2020:1⁃5. doi: 10.1080/09546634.2020.1735615.
［21］	Olamiju B, Craiglow BG. Tofacitinib cream plus narrowband ultraviolet B phototherapy for segmental vitiligo in a child［J］. Pediatr Dermatol, 2020,37（4）:754⁃755. doi: 10.1111/pde.14159.
［22］	Hesseler MJ, Shyam N. Platelet⁃rich plasma and its utility in medical dermatology: a systematic review［J］. J Am Acad Dermatol, 2019,81（3）:834⁃846. doi: 10.1016/j.jaad.2019.04.037.
［23］	Ibrahim ZA, El⁃Ashmawy AA, El⁃Tatawy RA, et al. The effect of platelet⁃rich plasma on the outcome of short⁃term narrowband⁃ultraviolet B phototherapy in the treatment of vitiligo: a pilot study［J］. J Cosmet Dermatol, 2016,15（2）:108⁃116. doi: 10.1111/ jocd.12194.
［24］	Parambath N, Sharma VK, Parihar AS, et al. Use of platelet⁃rich plasma to suspend noncultured epidermal cell suspension improves repigmentation after autologous transplantation in stable vitiligo: a double⁃blind randomized controlled trial［J］. Int J Dermatol, 2019,58（4）:472⁃476. doi: 10.1111/ijd.14286.
［25］	Khattab FM, Abdelbary E, Fawzi M. Evaluation of combined excimer laser and platelet⁃rich plasma for the treatment of nonsegmental vitiligo: a prospective comparative study［J］. J Cosmet Dermatol, 2020,19（4）:869⁃877. doi: 10.1111/jocd.13103.
［26］	Mercuri SR, Vollono L, Paolino G. The usefulness of platelet⁃rich plasma （PRP） for the treatment of vitiligo: state of the art and review［J］. Drug Des Devel Ther, 2020,14:1749⁃1755. doi: 10.2147/DDDT.S239912.
［27］	Kim WI, Kim S, Lee SH, et al. The efficacy of fractional carbon dioxide laser combined with narrow⁃band ultraviolet B phototherapy for non⁃segmental vitiligo: a systematic review and meta⁃analysis［J］. Lasers Med Sci, 2021,36（1）:165⁃173. doi: 10.1007/s10103⁃020⁃03069⁃0.
［28］	Mohammad TF, Hamzavi IH. Surgical therapies for vitiligo［J］. Dermatol Clin, 2017,35（2）:193⁃203. doi: 10.1016/j.det.2016.11. 009.
［29］	Ezz⁃Eldawla R, Abu El⁃Hamd M, Saied SM, et al. A comparative study between suction blistering graft, mini punch graft, and hair follicle transplant in treatment of patients with stable vitiligo［J］. J Dermatolog Treat, 2019,30（5）:492⁃497. doi: 10.1080/09546634. 2018.1528329.

[1]	Dai Yeqin, Song Xiuzu. Application of hair follicle transplantation and follicular cell suspension transplantation in the treatment of vitiligo [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230274-e0230274.
[2]	Sun Weiwei, Chen Jianru, Li Shuli, Gao Tianwen, Li Chunying . Analysis of depression-like behavioral performances of mouse models of vitiligo [J]. Chinese Journal of Dermatology, 2024, 57(2): 147-154.
[3]	Wang Haoyang, Wang Yidan, Lu Yan . Role of neurogenic inflammatory factors in the pathogenesis of vitiligo [J]. Chinese Journal of Dermatology, 2024, 57(1): 78-81.
[4]	Wang Tao, Wu Yi, Jin Hong, Dai Yeqin, Peng Jianzhong, Xu Ai′e, Song Xiuzu. Efficacy of electrolysis of depigmented hair combined with hair follicle transplantation in the treatment of 25 cases of vitiligo-associated leukotrichia: a retrospective analysis [J]. Chinese Journal of Dermatology, 2024, 57(1): 46-49.
[5]	Guliziba·Tuersun, Qu Yuanyuan. New advances in the treatment of vitiligo with JAK-STAT inhibitors [J]. Chinese Journal of Dermatology, 2024, 57(1): 71-75.
[6]	Chen Hui, Li Bing, Li Chunying, Guo Weinan . Comparison of the efficacy of water jet-assisted dermabrasion versus electric dermabrasion in combination with suction blister epidermal grafting in the treatment of vitiligo [J]. Chinese Journal of Dermatology, 2024, 57(1): 43-45.
[7]	He Kaiqiao, Li Shuli, Li Baizhang, Liu Ling, Li Chunying. Clinical observation of repigmentation patterns in patients with vitiligo treated with phototherapy and analysis of their influencing factors [J]. Chinese Journal of Dermatology, 2024, 57(1): 23-28.
[8]	Ma Jingjing, Kang Pan, Guo Sen, Jian Zhe, Li Chunying, Li Shuli. Expression patterns of transcription factor TFAP2B in epidermal melanocytes in healthy individuals and vitiligo patients [J]. Chinese Journal of Dermatology, 2024, 57(1): 29-33.
[9]	Zhang Qian, Zhang Jin′e, Guo Sen, Song Pu, Gao Lin, Li Chunying. Comparison of the efficacy of fractional CO2 laser combined with topical delivery of fluorouracil versus compound betamethasone injections in the treatment of vitiligo: a clinical observation [J]. Chinese Journal of Dermatology, 2024, 57(1): 34-38.
[10]	Xuan Yijie, Yang Yiwen, Wang Chen, Xu Zhongyi, Xiang Leihong, Zhang Chengfeng. Investigation of clinical factors influencing the response to systemic glucocorticoid treatment in patients with progressive non-segmental vitiligo [J]. Chinese Journal of Dermatology, 2024, 57(1): 17-22.
[11]	Li Shuli, Li Chunying. Clinical application of targeted drugs in vitiligo: progress and prospects [J]. Chinese Journal of Dermatology, 2024, 57(1): 12-16.
[12]	Li Chunying, Chen Jianru, Li Shuli. Metabolic reconfiguration in vitiligo: progress and future [J]. Chinese Journal of Dermatology, 2024, 57(1): 8-11.
[13]	Dai Leheng, Hu Wen, Zhang Kunjie, Kang Xiaojing. Protective effects of isorhamnetin against H2O2-induced mitochondrial structural and functional damage in HaCaT cells [J]. Chinese Journal of Dermatology, 2023, 56(9): 857-861.
[14]	Jia Weixue, Li Chengrang. Comparison of Chinese and international guidelines and consensus for the diagnosis and treatment of vitiligo [J]. Chinese Journal of Dermatology, 2023, 56(5): 471-475.
[15]	Chen Yi, Song Xiuzu. Role of transient receptor potential channels in melanocytes and their related diseases [J]. Chinese Journal of Dermatology, 2023, 56(4): 376-379.

Narrow-band ultraviolet B phototherapy combined with other therapies for the treatment of vitiligo

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［29］

Related Articles 15

Metrics

Comments

Recommended 10